Nutritional status in peritoneal dialysis: Studies in body composition, lipoprotein metabolism and peritoneal function

Scandinavian Journal of Urology and Nephrology, Supplement

Volumn 36, Issue 209, 2002, Pages 7-31

  Johansson, Ann Cathrine ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POTASSIUM; TRITIUM; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; WATER;

ADULT; AGED; ARTICLE; BODY COMPOSITION; COMORBIDITY; COMPARTMENT MODEL; CONTROLLED STUDY; FEMALE; HUMAN; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PERITONEAL DIALYSIS; PERITONEUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; SCORING SYSTEM; STATISTICAL ANALYSIS; TOTAL BODY WATER; VALIDATION PROCESS; BLOOD; BODY MASS; BODY WATER; METABOLISM; MIDDLE AGED; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

AGED; BIOLOGICAL TRANSPORT; BODY COMPOSITION; BODY MASS INDEX; BODY WATER; CREATININE; FEMALE; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PERITONEAL DIALYSIS; PERITONEUM; POTASSIUM;

EID: 0036011116     PISSN: 03008886     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (175)

1. Historical developments and overview over peritoneal dialysis
2. CAPD viability: A long-term comparison with hemodialysis
3. Mortality and technique failure in patients starting chronic peritoneal dialysis: Results of the Netherlands Cooperative Study on the Adequacy of Dialysis
4. Comparative mortality of hemodialysis and peritoneal dialysis in Canada
5. Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates
6. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis
7. A comparison of survival among dialytic therapies of choice: In-center hemodialysis versus continuous peritoneal dialysis at home
8. Trends in mortality on peritoneal dialysis: Canada, 1981-1997
9. Survival on renal replacement therapy in Europe: Is there a 'centre effect'?
10. Variable mortality rates among dialysis treatment centres
11. What happens to patients starting dialysis in the Netherlands?
12. Mode of dialysis therapy and mortality in end-stage renal disease
13. The impact of residual renal function on the adequacy of peritoneal dialysis
14. The impact of residual renal function on the adequacy of peritoneal dialysis
15. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes
16. Peritoneal solute transport predicts survival on CAPD independently of residual renal function
17. Peritoneal dialysis adequacy and risk of death
18. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients
19. Higher membrane permeability predicts poorer patient survival
20. Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients
21. Have we underestimated the importance of fluid balance for the survival of PD patients?
22. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity
23. Functional characteristics of the peritoneal membrane in long-term continuous ambulatory peritoneal dialysis
24. Longitudinal changes in peritoneal kinetics: The effects of peritoneal dialysis and peritonitis
25. Functional longevity of the human peritoneum: How long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study
26. Primary associates of mortality among dialysis patients: Trends and reassessment of Kt/V and urea reduction ratio as out-come based measures of dialysis dose
27. Body weight-for-height relationships predict mortality in maintenance hemodialysis patients
28. Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients
29. Nutrition and adequacy of dialysis. How do hemodialysis and CAPD compare?
30. Nutritional status of patients on hemodialysis and peritoneal dialysis
31. Nutritional assessment of continuous ambulatory peritoneal dialysis patients: An international study
32. Cross-sectional comparison of malnutrition in continuous ambulatory peritoneal dialysis and hemodialysis patients
33. Kinetics of peritoneal protein loss during CAPD: I. Different characteristics for low and high molecular weight proteins
34. Kinetics of peritoneal protein loss during CAPD: II. Lipoprotein leakage and its impact on plasma lipid levels
35. Peritoneal dialysis and loss of proteins: A review
36. Why are dialysis patients malnourished?
37. How much peritoneal dialysis is required for maintenance of a good nutritional status?
38. Predictors of survival in continuous ambulatory peritoneal dialysis patients: A five-year prospective study
39. Total Body Nitrogen as a prognostic marker in maintenance dialysis
40. Is serum albumin an index of nutritional status in continuous ambulatory peritoneal dialysis patients?
41. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome)
42. ApoB-containing lipoproteins in renal failure - The relation to mode of dialysis
43. Nitrogen and urea metabolism during continuous ambulatory peritoneal dialysis
44. Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis
45. Nutritional requirements of peritoneal dialysis patients
46. Höjde- og vektundersökelser hos voksne menn og kvinner. Förslag til nye norske höyde-vektnormer
47. Nya längd-vikt-tabeller för medelålders och äldre män och kvinnor
48. Body composition. Prediction of normal body potassium, body water and body fat in adults on the basis of body height, body weight and age
49. Total body water volumes for adult males and females estimated from simple anthropometric measuremants
50. A new whole body monitoring laboratory
51. Techniques for estimating body composition
52. Estimation of total body fat from potassium-40 content
53. Urinary creatinine excretion and lean body mass
54. Lean body mass estimations by creatinine kinetics
55. Comparison of different measurements of lean body mass in normal individuals and in chronic peritoneal dialysis patients
56. Creatinine metabolism in chronic renal failure
57. A proposed mechanism for reduced creatinine excretion in severe chronic renal failure
58. Estimation of human body surface area from height and weight
59. Studies on the mechanism of hypertriglyceridemia in Tangier disease: Determination of plasma lipolytic activities, ki values and apolipoprotein composition of the major lipoprotein density classes
60. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
61. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol
62. Determination of apolipoprotein A and its consistutive AI and AII polypeptides by separate electroimmunoassays
63. Electroimmunoassay, radioimmunoassay and radial immunodiffusion assay evaluated for quantification of human apolipoprotein B
64. Determination of human apolipoprotein E by electroimmunoassay
65. Quantitative determination of apolipoprotein C-III by electroimmunoassay
66. Serum apolipoprotein profile of patients with chronic renal failure
67. Differential electroimmunoassay of human LP-AI lipoprotein particles on ready-to-use plates
68. Effects of lovastatin on apoA- and apoB-containing lipoprotein families in a subpopulation of patients participating in the Monitored Atherosclerosis Regression Study (MARS)
69. Transport of macromolecules across microvascular walls: The two-pore theory
70. A three-pore model of peritoneal transport
71. Clinical implications of a three-pore model of peritoneal transport
72. Simulations of peritoneal solute transport during CAPD. Application of two-pore formalism
73. How does peritoneal dialysis remove small and large molecular weight solutes? Transport pathways: Fact and myth
74. Computer simulations of peritoneal fluid transport in CAPD
75. Understanding the kinetics of peritoneal transport
76. Assessing the individual Peritoneal Dialysis Capacities of individual patients. A clinical tool based on the three-pore model
77. Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis
78. How to evaluate and optimize peritoneal dialysis treatment
79. Influence of coexisting disease on survival of renal-replacement therapy
80. Death during the first 90 days of dialysis: A case control study
81. Quality of life over time in dialysis: The Netherlands Cooperative Study on the Adequacy of Dialysis
82. Advance prediction of early death in patients starting maintenance dialysis
83. Prediction of early death in end-stage renal disease patients starting dialysis
84. Statistical methods for assessing agreements between two methods of clinical measurements
85. Assessments of body potassium stores
86. Water, electrolyte and glycogen content in muscle tissue in patients undergoing regular dialysis therapy
87. Muscle biopsy water and electrolyte contents in chronic renal failure
88. Relationship between muscle potassium and total body potassium in infants with malnutrition
89. Muscle intracellular electrolytes in patients with chronic uremia
90. Muscle water and electrolytes in patients undergoing continuous ambulatory peritoneal dialysis
91. In vivo measurements of body protein based on the determination of nitrogen by prompt gamma analysis
92. Critical evaluation of the role of clinical assessment and body composition studies in patients with malnutrition and after total parenteral nutrition
93. Nutritional and anthropometric assessment on patients on CAPD over one year: Contrasting changes in total body nitrogen and potassium
94. Nutritional status of patients undergoing continuous ambulatory peritoneal dialysis
95. Nutritional status on patients on long time PD
96. 2H labeled water
97. Measuring total body water in peritoneal dialysis patients using an ethanol dilution technique
98. Total body water and the exchangeable hydrogen I. Theoretical calculations of nonaqueous exchangeable hydrogen in man
99. Relationship between total body water and surface area in normal and obese subjects
100. Development of a population-specific regression equation to estimate total body water in hemodialysis patients
101. Normalization of clearances in peritoneal dialysis using a formula for body water derived from an end-stage renal disease population
102. Total body water and body composition in chronic peritoneal dialysis patients
103. Assessment of total body water and lean body mass from anthropometry, Watson formula, creatinine kinetics, and body electrical impedance compared with antipyrine kinetics in peritoneal dialysis patients
104. Measurement of total body water and urea kinetic modelling in peritoneal dialysis
105. Kt/V in CAPD by different estimations of V
106. Comparing different methods of assessing body composition in end-stage renal failure
107. Measurement of muscle mass in humans: Validity of the 24-hour urinary creatinine method
108. Total body skeletal muscle mass: Evaluation of 24-h urinary creatinine excretion by computerized axial tomography
109. Creatinine Metabolism in Humans with Decreased Renal Function: Creatinine Deficit
110. Creatinine Excretion as a Measure of Protein Nutrition in Adults of Varying Age
111. Creatinine excretion: Variability and relationships to diet and body size
112. Constancy of urinary creatinine excretion
113. Urinary creatinine excretion as an index of the completeness of 24-hour urine collections
114. The variability of creatinine excretion in normal subjects, mental patients and pregnant women
115. Variability of creatinine excretion of normal, phenylketonuric and galactosemic children, and children treated with anti-convulsant drugs
116. Creatinine excretion
117. Variability of creatinine excretion in preadolescent girls consuming a wide range of dietary nitrogen
118. Lean body mass by dual energy X-ray absorptiometry (DEXA) and by urine and dialysate creatinine recovery in CAPD and pre-dialysis patients compared to normal subjects
119. Total body protein status assessed by different estimates of fat-free mass in adult peritoneal dialysis patients
120. Percentage body fat determination in hemodialysis and peritoneal dialysis patients: A comparison
121. Studies on body composition; body water and chemically combined nitrogen contents in relation to fat contents
122. Hydration of fat-free body mass: Review and critique of a classic body-composition constant
123. Body cell mass and limits of hydration of the fat-free body: Their relation to estimated skeletal weight
124. Metabolically active component of fat-free body mass: Influences of age, adiposity and gender
125. Total body potassium - A guide to nutritional health in patients undergoing continuous ambulatory peritoneal dialysis
126. A longitudinal study in body composition in terminal uremics treated by regular hemodialysis
127. Body composition in chronic renal failure
128. Total body electrolyte composition and distribution of body water in uremia
129. Evaluation of body composition and nitrogen content of renal patients on chronic dialysis as determined by total body neutron activation
130. The composition of the body in renal failure
131. Serial measurement of total body potassium in chronic renal disease
132. Vintage, nutritional status and survival in hemodialysis patients
133. Whole body and regional body composition in patients with chronic renal failure
134. Impact of dialysis modality on body composition in patients with end-stage renal disease
135. Influence of trauma and disease
136. Body composition of patients with malnutrition and cancer. Summary of methods of assessment
137. A comparison between muscle function and body composition in anorexia nervosa: The effect of refeeding
138. Mechanisms causing loss of lean body mass in kidney disease
139. Metabolic acidosis and skeletal muscle adaptation to low protein diets in chronic uremia
140. Protein metabolism in patients with chronic renal failure: Role of uremia and dialysis
141. Whole body leucine turnover and nutritional status in continuous ambulatory peritoneal dialysis
142. Uremia and the control of protein metabolism
143. Impact of peritoneal absorption of glucose on appetite, protein catabolism and survival in CAPD patients
144. Effect of energy intake on nitrogen metabolism in nondialyzed patients with chronic renal failure
145. Eating behaviour in continuous ambulatory peritoneal dialysis patients and hemodialysis patients
146. Appetite in CAPD patients
147. Changes in patients' eating behavior: In the uremic state, on continuous ambulatory peritoneal dialysis treatment, and after transplantation
148. Muscle strength and function improves with endurance exercise training in maintenance hemodialysis patients
149. Analysis of the effects of increasing delivered dialysis treatment to malnourished peritoneal dialysis patients
150. An evaluation of an integrative care approach for end-stage renal disease patients
151. Methods for assessing nutritional status in patients with renal failure
152. Lipid metabolism and renal failure
153. Abnormalities of lipoprotein metabolism in CAPD patients
154. Effects of the three treatment modes on plasma lipids and lipoproteins in uremic patients
155. Triglyceride-rich lipoprotein abnormalities in CAPD-treated patients
156. Longitudinal lipid profiles on CAPD: Their relationship to weight gain, comorbidity, and dialysis factors
157. Serum lipids and lipoproteins during continuous ambulatory peritoneal dialysis
158. Apo AIV in plasma and dialysate fluid of CAPD patients: Comparison with other apolipoproteins
159. Lipoprotein and apolipoprotein losses during continuous ambulatory peritoneal dialysis
160. The relationship between plasma and dialysate lipoproteins and apoproteins in patients treated by continuous ambulatory peritoneal dialysis
161. Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis
162. The lipoprotein family concept and its clinical significance
163. Peritoneal equilibration test
164. o/Δx) is a better indicator of peritoneal membrane function that PET
165. Clinical application of the peritoneal dialysis capacity (PDC) test
166. Peritoneal Dialysis Capacity (PDC) test: A multicenter clinical validation study
167. The predictive value of KT/V and peritoneal solute transport in CAPD patients is dependent on the type of comorbidity present
168. Small-solute clearances in diabetic subjects on continuous ambulatory peritoneal dialysis: Comparison to nondiabetic subjects
169. Relation of calcified macroangiopathy to peritoneal small solute transport property
170. Creatine and creatinine metabolism in uraemia
171. A longitudinal, five year survey of urea kinetic parameters in CAPD patients
172. Stability of the peritoneal membrane in long-term peritoneal dialysis patients
173. What really happens to people on long-term peritoneal dialysis?